Molecular diagnosis contribution for personalized medicine

被引:2
|
作者
Luengo, Olga [1 ,2 ,3 ,4 ]
Galvan-Blasco, Paula [1 ,2 ,3 ,4 ]
Cardona, Victoria [1 ,2 ,3 ,4 ]
机构
[1] Hosp Univ Vall Hebron, Allergy Sect, Dept Internal Med, Passeig Vall Hebron 119-129, Barcelona 08035, Spain
[2] Vall Hebron Inst Recerca VHIR, Immunomediated Dis & Innovat Therapies, Barcelona, Spain
[3] Inst Salud Carlos III ISCIII, ARADyAL Res Network, Madrid, Spain
[4] Univ Autonoma Barcelona UAB, Dept Med, Barcelona, Spain
关键词
component resolved diagnosis; immunoglobulin E; molecular allergy; precision medicine; ARA H 2; ALLERGEN COMPONENTS; PEANUT ALLERGY; ACCURACY; RHINITIS;
D O I
10.1097/ACI.0000000000000822
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review The purpose of the current review is to highlight the most recent findings in molecular allergy and its applicability in precision medicine for allergic patients. Recent findings Molecular allergy provides useful information in areas of respiratory allergy (house dust mites, pet dander and pollen allergy), food allergy (tree nuts, peanuts, fruits and vegetables), hymenoptera venom allergy and others, in order to improve management of patients. Regional differences in sensitization profiles, assay characteristics and interpretation of molecular sensitization in relation to whole extracts and total immunoglobulin E need to be taken into account. Studies of the impact of such strategies are needed. Molecular allergy diagnosis represents a major contribution for personalized medicine. It aids in the assesment of risk prediction, disease severity, genuine/cross-reactive sensitization, and finally to apply precise management strategies.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 50 条
  • [1] Contribution of biomarkers to personalized medicine
    Hayes, Daniel F.
    BREAST CANCER RESEARCH, 2010, 12
  • [2] Contribution of biomarkers to personalized medicine
    Daniel F Hayes
    Breast Cancer Research, 12
  • [3] Molecular Imaging for Personalized Medicine
    Russell, James
    Tian, Jie
    Kinuya, Seigo
    Shen, Baozhong
    Li, Xiao-Feng
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [4] MOLECULAR CYTOPATHOLOGY AND PERSONALIZED MEDICINE
    Salto-Tellez, M.
    ACTA CYTOLOGICA, 2010, 54 (03) : 385 - 385
  • [5] Molecular medicine: a path towards a personalized medicine
    de Miranda, Debora Marques
    Mamede, Marcelo
    de Souza, Bruno Rezende
    de Almeida Barros, Alexandre Guimaraes
    Magno, Luiz Alexandre
    Alvim-Soares, Antonio, Jr.
    Rosa, Daniela Valadao
    de Castro, Celio Jose, Jr.
    Malloy-Diniz, Leandro
    Gomez, Marcus Vinicius
    De Marco, Luiz Armando
    Correa, Humberto
    Romano-Silva, Marco Aurelio
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2012, 34 (01) : 82 - 91
  • [6] Molecular Testing in Colorectal Cancer Diagnosis of Lynch Syndrome and Personalized Cancer Medicine
    Shi, Chanjuan
    Washington, Kay
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (06) : 847 - 859
  • [7] Progress in oral personalized medicine: contribution of 'omics'
    Glurich, Ingrid
    Acharya, Amit
    Brilliant, Murray H.
    Shukla, Sanjay K.
    JOURNAL OF ORAL MICROBIOLOGY, 2015, 7
  • [8] Precision Diagnosis for the Era of Personalized Medicine
    Huang, Lin
    Qian, Kun
    SMALL METHODS, 2020, 4 (04)
  • [9] Is there any contribution of bronchial washing to biopsy in the diagnosis of patients with endobronchial pathology in the era of personalized medicine?
    Karcioglu, Oguz
    Sarinc Ulasl, Sevinc
    Babaoglu, Elif
    Keles, Emine
    Ozden Sertcelik, Umran
    Onder, Sevgen
    Koksal, Deniz
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2021, 69 (03): : 307 - 313
  • [10] 'PERSONALIZED MEDICINE' IS THE ERA SHIFTING FROM 'MOLECULAR TREATMENT' TO 'MOLECULAR DIAGNOSIS'; EXPERIENCE FROM BREAST CANCER
    Saji, S.
    Sato, F.
    ANNALS OF ONCOLOGY, 2012, 23 : 72 - 72